Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

por Hsu, Jeff, Chong, Colin, Serrill, Jeffrey, Goon, Levina, Balayan, Joan, Johnson, Eric N., Lorenzana, Grachelle, Wu, Sharon, Leong, Kevin G., Yun, Theodore J., Wang, Yong, Jiang, Faming, Bannen, Lynne, Lamb, Peter, Xu, Wei, Yu, Peiwen
Publicado 2023